Encorafenib is an oral medication approved by the FDA for the treatment of unresectable or metastatic melanoma. It is further specified for the use of patients with BRAF V600E or V500K mutation. Encorafenib is also indicated for the treatment of colorectal cancer in combination with cetuximab. In the case of colorectal cancer, the specific indication is for the metastatic CRC with BRAF V600E mutation. In melanoma treatment, it is used in combination of binimetinib. Braftovi is the trade name for this drug and is commercially available as 75mg capsules. Encorafenib in India is procured based on the expert advice through import channels.
Braftovi 75mg capsules are available in a bottle of 90 capsules. A commercial pack contains two such bottles. The dosage for melanoma is 450mg per day and CRC is 300mg per day. This can be altered based on the clinical experience and response to the medication by the treating physicians. This drug is indicated and approved only in adult patients and there is no credible evidence for paediatric cases. The duration of treatment is not clearly specified. It should be continued till disease progression or tolerability considerations are noted.
Encorafenib is an innovative drug developed by Novartis and further promoted by Array BioPharma. It was granted the approval by the US FDA in 2018. It is a kinase inhibitor that is known by its function of inhibiting BRAF gene. It has a unique mechanism of action that helps in slowing or stopping the growth of cancer cells.
The import process of advanced and lifesaving medicines in India shall be determined by specific regulatory procures. It can be initiated by procuring the physician’s prescription for the entire quantity as required. An Oncologist is usually authorised to issue such a prescription.
Patients have the provision of uploading the prescription and a copy of the ID card issued by the central government along with the import permit application online. CDSCO facilities the same. It is also the governing body in this regard.
Securing the import permit would make it simpler for you to approach an authorized source and place an order. You should essentially identify the supplier or vendor from the regions where Encorafenib is available.
Braftovi India import process has to be authenticated by the customs clearance. There are again specific set of documents that are required to be filled in and submitted for the sake of clearance at the port of entry opted by you.
Delivery of medicines as per your preferred location is an option you can work out with your supplier. If you are not hospitalized, you can very well consider home delivery of these drugs as per the packaging specifications.
1. Your sources need to be thoroughly validated for your satisfaction. It is important that you are not getting duped by traders who are not authorized to deal with such speciality medications. Encorafenib India procurement has to be done by considering all the legal restrictions as well.
2. Do not consider making payments offline. Always use the safe banking procedures to securely transfer payments to your international vendors. You must have enough confidence and controls while doing the same.
3. All import processes are to be supported by legal documents. They must include a commercial invoice and Bill of entry from the customs. If you have reimbursement claims to make, these documents are supposed to be in fair order.
Synergy Drugs provides assistance to patients with reliable information regarding the access to drugs like Encorafenib in India. We bring in the experience of expert professionals from the industry. They understand all the key aspects of importing speciality medicines. We will also guide you with identifying the right supplier or vendor for this drug. You can fully rely on our access information.